Wedbush Predicts Tourmaline Bio FY2024 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Wedbush issued their FY2024 EPS estimates for shares of Tourmaline Bio in a research note issued on Thursday, March 6th. Wedbush analyst L. Chico expects that the company will post earnings per share of ($2.78) for the year. Wedbush has a “Outperform” rating and a […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Wedbush issued their FY2024 EPS estimates for shares of Tourmaline Bio in a research note issued on Thursday, March 6th. Wedbush analyst L. Chico expects that the company will post earnings per share of ($2.78) for the year. Wedbush has a “Outperform” rating and a […]
